taVNS for Acute Intracerebral Hemorrhage
TaVNS for Acute Intracerebral Hemorrhage
Recruiting
N/A
Interventional Study
Intracerebral Hemorrhage
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 186 (estimated)
- Sponsor
- Beijing Tiantan Hospital · Other
Who this trial is looking for
This trial is looking for adults aged 18 to 80 who have had a recent brain hemorrhage. Participants will receive a type of nerve stimulation therapy to see if it helps reduce swelling in the brain.
Are You a Good Fit for This Trial?
You may be able to join if
- I have had a spontaneous brain hemorrhage.
- I am between 18 and 80 years old.
- My hemorrhage started within the last 72 hours.
- I have a hematoma volume between 5 and 40 mL.
- My Glasgow Coma Scale score is greater than 8.
- I or my legal representative can provide written consent.
You may not be able to join if
- I have had a secondary brain hemorrhage.
- I have primary intraventricular hemorrhage.
- I have severe heart issues.
- I have severe pulmonary disease or liver disease.
- I have a serious neurological disease.
- I cannot tolerate taVNS.
- I am pregnant or have just given birth.
- I cannot provide written consent.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to evaluate the efficacy and safety of transcutaneous auricular vagus nerve stimulation (taVNS) in patients with acute intracerebral hemorrhage (ICH). The taVNS intervention will be delivered using the BS-TVNS800-1 transcutaneous electrical stimulation therapy device (KERFUN, Shanxi, China). A total of 186 patients will be randomly assigned in a 1:1 ratio to either the taVNS group …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Patients with spontaneous supratentorial intracerebral hemorrhage.
2. Age between 18 and 80 years.
3. Onset within 72 hours.
4. Hematoma volume between 5 and 40 mL.
5. Glasgow Coma Scale (GCS) score greater than 8.
6. Written informed consent obtained from the patient or thei…
Contacts
No contact information available.